Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tumor Lysis Syndrome 2 Lymphoma 1 Leukemia 1 Inflammation 1 Hyperuricemia 1 Hematologic Neoplasms 1 Gout 1 Cardiovascular Diseases 1 Carcinoma, Non-Small-Cell Lung 1 Arthritis 1

Interventions

Nutrition Assessment 2 Collagenases 2 upadacitinib 1 tocilizumab 1 methyl hydroxyethyl cellulose 1 acetaminophen, aspirin, caffeine drug combination 1 Walking 1 Vaccines 1 Transcutaneous Electric Nerve Stimulation 1 Saline Solution 1 Resistance Training 1 Radiotherapy 1 Omeprazole 1 Naproxen 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Lysine Acetyltransferase 5 1 Injections, Intra-Articular 1 Infliximab 1 Immune Checkpoint Inhibitors 1 Holistic Health 1 Herpes Zoster Vaccine 1 Febuxostat 1 Exergaming 1 Exercise Therapy 1 Etanercept 1 Colchicine 1 Cari-D-Tect 1 Blood Specimen Collection 1 Arthroplasty, Replacement, Shoulder 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Arthritis × Febuxostat × Clear all

NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed

196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡